Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
10.1016/s0898-6568(01)00186-183 Cell
No high-quality clinical trials have specifically investigated microdosing as a therapeutic strategy
Kedees MH, Guz Y, Grigoryan M, Teitelman G
As an agonist at amylin and calcitonin receptors, cagrilintide is being investigated for its effect on appetite, food intake, and bodyweight, and it is engineered for a duration that supports once-weekly subcutaneous dosing
Additional Notes Suitable for both in vitro and in vivo research applications Summary Table Disclaimer For Research Use Only
This product has been manufactured in a cGMP facility
US$ 28.13
US$ 28.27
US$ 25.28
US$ 26.14
